To compare 26-h glycemic responses to uninterrupted sitting versus hourly brisk walking breaks and an alternating walking–resistance break strategy in sedentary young adults, with exploratory sensitivity analyses adjusting for energy expenditure (EE). Eighteen sedentary, healthy young adults (11 female; age, mean (SD) = 23.7 (2.5) years; BMI, 21.2 (2.0) kg/m2) completed three 26-h laboratory protocols in a randomized crossover design. Each protocol included a 22-h stay in a metabolic chamber and one 9-h intervention: uninterrupted sitting (SIT), 8-min bouts of brisk walking at 60% VO2max every 60 min (WALK), or alternating 8-min bouts of simple resistance activities and brisk walking every 60 min (RESWALK). Interstitial glucose was recorded every 5 min by continuous glucose monitoring across the all three 26-h trials; the primary outcome was 26-h glucose incremental area under the curve (iAUC). The primary outcome, 26-h glucose iAUC, showed a significant condition effect (overall p = 0.039). Compared with SIT, RESWALK reduced 26-h iAUC by 17.3% (Cohen's d = −0.61, 95% CI −1.09 to −0.12; p = 0.043), while the reduction in WALK was not significant; these effects were attenuated after adjusting for EE (p = 0.085). For secondary outcomes, both WALK and RESWALK reduced glucose iAUC during the 9-h intervention window (p ≤ 0.027), with RESWALK being more effective than WALK (p = 0.021). However, during the 5-h evening period, iAUC was higher in WALK compared with SIT (p = 0.011), while no differences were observed during the 8-h sleep period. Regarding glucose variability, only CONGA_1 was significantly lower in RESWALK versus SIT (p ≤ 0.041). Compared with prolonged sitting, interrupting sedentary behavior with hourly breaks of combined walking and resistance exercises improves 26-h glycemic control in healthy young adults, EE-adjusted sensitivity analyses attenuated the 26-h effect. Walking-only breaks provided daytime benefits but did not significantly improve 26-h glucose exposure. ChiCTR1800019120.
Background: Mild cognitive impairment (MCI) is a prevalent complication of type 2 diabetes mellitus (T2DM). Cognitive impairment progressively impairs self-care abilities, thereby triggering a vicious cycle of poor glycemic control and further cognitive decline. Exercise has been widely recognized as an effective strategy to improve both glycemic control and cognitive function; however, an optimal time of day for exercise to mitigate this neurodegenerative trajectory has not been determined. This trial aims to determine the most effective exercise timing to maximize cognitive benefits in older T2DM patients with MCI (T2DM-MCI) and to investigate the underlying neurobiological mechanisms using multimodal magnetic resonance imaging. Methods: In this randomized controlled trial, patients 60–75 years of age with T2DM‐MCI will be assigned to a morning exercise group (09:00–10:10), an evening exercise group (19:00–20:10), or a health education group. The exercise groups will complete a 12-week, home-based, remotely supervised exercise program comprising aerobic and resistance exercises. The health education group will receive a 12-week health education program. Cognitive function will be evaluated at baseline and post-intervention using the Montreal Cognitive Assessment, Color-Word Stroop Test, N-back task, Trail making Test, Attention Network Test, and Digit Symbol Substitution Test. Additionally, brain structure and function based on imaging, blood biomarkers, and physical fitness will also be assessed. Discussion: In this study, we aim to identify the optimal time of day for exercise to maximize cognitive benefits in patients with T2DM‐MCI and to elucidate underlying neurocognitive mechanisms. We will examine whether glycemic control mediates the relationship between exercise and cognitive function improvement. This research is expected to provide “time-specific” evidence for exercise prescription to maximize the neurocognitive benefits and mitigate dementia risk in this population. Trial registration: Chinese Clinical Trial Registry: [ http://www.chictr.org.cn ], identifier [ChiCTR2300073737].